Skip to main content
CRS 2024 Annual Meeting and Exposition Main banner
Final Program


CRS Abstract Guide
Back

Session: Workshop: The Application of AI to Drug Delivery and Controlled Release

Workshop The Application of AI to Drug Delivery and Controlled Release

Monday, July 8, 2024
8:00 AM – 12:00 PM CET
Location: Emilia

Sponsored By 
The workshop addresses the pressing need for innovative solutions in drug delivery, especially for nucleic acids/macromolecules, by exploring the transformative potential of AI and computational tools to revolutionize the field. Geared towards academics and biotech industry professionals, our goals include fostering collaboration, sharing cutting-edge research, and facilitating discussions on how AI can best facilitate research and development of drug delivery technologies. We will invite top researchers and companies to create a forum to share new ideas. Attendees will learn the latest advancements while exploring potential applications. The workshop will focus solely on knowledge exchange without product or service demonstrations


8:00 am to 8:30 am          Opening Remarks + Overview
                                         Avi Schroeder, PhD, Technion, Israel Institute of Technology
                                         Daniel Heller, PhD, Memorial Sloan Kettering Cancer Center


8:30 pm to 8:55 am          Integration of AI and Robotics in Drug Formulation Development
                                         Christine Allen, PhD, University of Toronto


8:55 am to 9:20 am          AI-Aided Development of Lipid Nanoparticles for mRNA Delivery
                                         Bowen Li, PhD, University of Toronto


9:20 am to 9:40 am          Networking Break


9:40 am to 10:05 am        Machine Learning-Based Discovery of Polymeric Nucleic Acid Delivery Vehicles
                                         Theresa Reineke, PhD, University of Minnesota


10:05 am to 10:30 am      Using an AI- and ML-powered LNP Design Platform to Develop 4-Component LNPs for Muscle Cell                                                       Targeting via Intravenous Administration
                                         Daniel F. Quevedo, PhD, METiS Therapeutics


10:30 am to 10:50 am      Adapting Digital Drug Discovery Tools for Drug Delivery
                                         Daniel Reker, DrSc, Duke University


10:50 am to 11:10 am      Networking Break


11:10 am to 11:35 am       AI Based Approaches for Combinatorial Cancer Nanomedicine
                                         Yosi Shamay, PhD, Technion, Israel Institute of Technology


11:35 am to 11:50 am       Award Speakers Session


11:35 am to 11:50 am       Closing Remarks

Learning Objectives:

At the completion of this activity, participants will know
  • Understand and explore the transformative potential of AI and computational tools to revolutionize drug delivery, including small molecules and nucleic acids.
  • Learn from top investigators from academia and industry on cutting-edge research in AI for drug delivery.
  • Facilitate discussions and collaborations to help investigators use AI to enable research and development of drug delivery technologies.
  • The workshop will focus solely on knowledge exchange without product or service demonstrations.